🟢 Chimeric Therapeutics is trading 16.67% up today with no clear company-specific catalyst

Chimeric Therapeutics is trading at A$0.01, up +16.67%, with no clear company-specific announcement dated September 21, 2026 explaining the move.

• Recent available coverage references a September 18 share-quotation application and earlier company updates, rather than a new September 21 catalyst.
• The gain appears consistent with low-priced-stock trading activity or market noise, rather than a confirmed fundamental event.
• Broader U.S. market context was broadly positive, but provided indices were flat at the latest close, so global sentiment is not a definitive explanation.